OXFORD UNIVERSITY
GAZETTE

No. 4437 Thursday 15 May 1997 Vol. 127

New gene therapy to target resistant cancers : Scientists at the Institute of Molecular Medicine have discovered a new approach in gene therapy with the potential to treat cancerous tumours that become resistant to drug and radiotherapy treatments.

Inquiry called on city traffic plans : Radical proposals to remove traffic from Oxford city centre will now be examined by a full public inquiry, following a decision by Oxfordshire County Council, the local traffic authority.

Sleep-out helps homeless in Oxford : The University Marshal, Mr Ted Roberts, joined seventy undergraduates sleeping `rough' in the University Parks on Saturday, 3 May, to raise money for homeless charities in Oxford.

Oxford standard raised in Atlanta : A`trinity Gathering' of alumni from across the south-eastern and mid-Atlantic United States was held in Atlanta on April 25–7 to promote fellowship among Oxonians, and enrich US alumni ties with the University.

Engineers get high marks for teaching : The Department of Engineering Science has scored 23 points out of a possible 24 in the Teaching Quality Assessment (TQA) recently completed by the Higher Education Funding Council for England.

Arthurian romance links Oxford and Bonn : Germanists from Bonn were welcomed to Oxford last week (5–11 May) for the ninth Oxford–Bonn Colloquium to debate German Arthurian romances, a fitting subject to mark the fiftieth anniversary of the twinnning of the cities of Oxford and Bonn.

Physiology award: Scientists at the Department of Physiology have received a £146,500 grant from the British Heart Foundation to fund a three-year research project into the study of abnormal heartbeats. The team, under Dr Kathryn Ryder, will investigate two closely linked heart diseases, hypertrophy and heart failure.

Technology transfer seminar: A seminar at the Oxford Science Park on 16 April focused on technology transfer. Industrialists and academics heard presentations from British Biotechnology, Oxford Lasers, a technology transfer lawyer, and Dr David Thomas of Isis Innovation. The seminar was organised by the Chamber of Commerce under its RESBIG—REsearch and Science Based Industry Group—series.

Professor Christopher Higgins: Professor Christopher Higgins, Nuffield Professor of Clinical Biochemistry, has been appointed as a Member of the Council for the Biotechnology and Biological Sciences Research Council.

Suggestions for items to be included in the Gazette
news pages are welcome, and should be sent to the
Press Office, telephone (2)78181, fax (2)78180.

| This week's Gazette Home Page | University Home Page |